Cancer of Breast / Behavioral Weight-loss Program Via Telehealth / Behavioral Weight-Loss Program Via Telehealth - Weight Measures · Interventional Study
ClinicalTrials.gov · August 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a prospective single-arm feasibility and acceptability study of a telehealth-delivered behavioral weight-loss intervention in breast cancer survivors, currently active but with no results yet posted to the registry. The study measures feasibility, acceptability, and patient-reported outcomes (quality of life, physical activity, depression) at 24 weeks, along with body mass and mammographic density changes. No efficacy data are yet available to inform clinical practice.
Interventional, Single Group, Open label, Treatment purpose. Cancer Survivors, Cancer of Breast, Body Weight, Overweight and Obesity; Female; age from 18 Years. Intervention: Single-Arms Longitudinal Group. n = 22. 1 site: United States.
This is a prospective single-arm feasibility and acceptability study of a telehealth-delivered behavioral weight-loss intervention in breast cancer survivors, currently active but with no results yet posted to the registry. The study measures feasibility, acceptability, and patient-reported outcomes (quality of life, physical activity, depression) at 24 weeks, along with body mass and mammographic density changes. No efficacy data are yet available to inform clinical practice.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
No clinical impact can yet be assessed from this registry record, as results have not been posted. Once completed, this feasibility study may inform design of larger controlled trials of telehealth weight-loss programs in this population.
This is a registry record for an active single-arm feasibility study with no results posted; it describes planned enrollment and endpoints only, not outcome data.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can yet be assessed from this registry record, as results have not been posted. Once completed, this feasibility study may inform design of larger controlled trials of telehealth weight-loss programs in this population.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT04855552). This is a study registration, not published results. Lead sponsor: Abramson Cancer Center at Penn Medicine. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 22 participants (ACTUAL). Conditions: Cancer Survivors, Cancer of Breast, Body Weight, Overweight and Obesity. Interventions: BEHAVIORAL: Behavioral Weight-loss Program Via Telehealth; BEHAVIORAL: Behavioral Weight-Loss Program Via Telehealth - Weight Measures; BEHAVIORAL: Validated Surveys of Patient-Reported Outcomes. Primary outcome measures: Determine feasibility and Acceptability Using the City of Hope Quality of Life Instrument - Breast Cancer Patient to Assess Changes in Quality of Life , 24 weeks; Determine feasibility and Acceptability Using the International Physical Activity Questionnaire to Assess Changes in Physical Activity , 24 weeks; Determine feasibility and Acceptability Using the Patient Health Questionnaire to Assess Changes in Measures of Depression , 24 weeks; Using the Acceptability of Intervention Measure to Assess Acceptability and Feasibility , 24 weeks; Requesting Direct Verbal Feedback From Participants to Assess Elements of the Program that Work Well, to Acquire Suggestions, and to Seek Suggestions to Determine Feasibility and Acceptability , 24 weeks. Brief summary: This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.